Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-K^AFSPEVIPMF-OH
3D-Ansicht

Biosynth logo

H-K^AFSPEVIPMF-OH

Ref. 3D-PP48823

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Mittwoch 6. November 2024

Produktinformation

Name:
H-K^AFSPEVIPMF-OH
Beschreibung:

Peptide H-K^AFSPEVIPMF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-K^AFSPEVIPMF-OH include the following: Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya YS Mohamed , NJ Borthwick , N Moyo, H Murakoshi - Vaccines, 2020 - mdpi.comhttps://www.mdpi.com/2076-393X/8/2/260 Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid XG Yu , M Lichterfeld, S Chetty, KL Williams - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01580-06 HIV-1 Epitope-Specific CD8 V Efficiently - J Immunol, 2006 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=31a987b00fdd46b2369317147f095732d14ff9e1 Strong TCR Conservation and Altered T Cell TD Easterbrook, EY Jones , L Sarah - J , 2006 - erepository.uonbi.ac.kehttp://erepository.uonbi.ac.ke/handle/11295/42340 affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations R Barquera , E Collen, D Di , S Buhler , J Teixeira - Hla, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/tan.13956 HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome PT Illing , P Pymm , NP Croft , HG Hilton , V Jojic - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-07109-w HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other PJR Goulder , Y Tang, SI Pelton, BD Walker - Journal of virology, 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.11.5291-5299.2000 Published Ahead of Print 22 November 2006. MA Goepfert, PJR Goulder , D Bruce, PK Rosenberg - J. Virol, 2007 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=e9e32fd666a0a0ab67088471f8d485dbc51c37b6 Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules L Fadda, GM O'Connor , S Kumar - Journal of , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00412-11 Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians JR Currier, ME Harris, JH Cox - AIDS Research & , 2005 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/aid.2005.21.239 Frequencies of Gag-restricted T-cell escape"footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles J Serwanga, R Nakiboneka, S Mugaba, B Magambo - Vaccine, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X15002261 Examining the sequence and function of HIV Gag-specific T cell receptors restricted by HLA-B* 57 and HLA-E HSA Hsieh - 2023 - summit.sfu.cahttps://summit.sfu.ca/item/37890 HIV-1 Gag Cytotoxic T Lymphocyte HLN Gall, OO Yang , A Balamurugan, A Ali, J Boucau - J. Virol, 2013 - researchgate.nethttps://www.researchgate.net/profile/Ayub-Ali-2/publication/237060757_HIV-1_Gag_Cytotoxic_T_Lymphocyte_Epitopes_Vary_in_Presentation_Kinetics_Relative_to_HLA_Class_I_Downregulation/links/5447cb980cf22b3c14e1a0fd/HIV-1-Gag-Cytotoxic-T-Lymphocyte-Epitopes-Vary-in-Presentation-Kinetics-Relative-to-HLA-Class-I-Downregulation.pdf Strong TCR conservation and altered T cell cross-reactivity characterize a B* 57-restricted immune response in HIV-1 infection G Gillespie, G Stewart-Jones, J Rengasamy - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/6/3893/73891 The Dynamic Interplay between HIV-1 and T cells CR Aguilera-Sandoval - 2016 - search.proquest.comhttps://search.proquest.com/openview/06b6c3a9738c35c5b147162e31d70a2c/1?pq-origsite=gscholar&cbl=18750 High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection CA Jansen, S Kostense - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425487 Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants BC Simons, SE VanCompernolle, RM Smith - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/181/7/5137/84352 Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations A Stavrakoudis - Cell biochemistry and biophysics, 2011 - Springerhttps://link.springer.com/article/10.1007/s12013-011-9151-2

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP48823 H-K^AFSPEVIPMF-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.